Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Price History
|
Ratios
|
Insiders
Bullboard - Stock Discussion Forum
Anavex Life Sciences Corporation
AVXL
Healthcare
Biotechnology
Anavex Life Sciences Corp. operates as a biopharmaceutical company. It engages in developing innovative treatments for Alzheimer’s disease, Parkinson’s disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) disorders, pain, and various types of cancer . Its lead drug candidate, ANAVEX 2-73 (blarcamesine),...
has completed a Phase 2a and a Phase 2b/3 clinical trial for Alzheimer's disease; a Phase 2 proof-of-concept study in Parkinson's disease dementia; and a Phase 2 and a Phase 3 study in adult patients and one Phase 2/3 study in pediatric patients with Rett syndrome. Its ANAVEX 2-73 is an orally available drug candidate designed to restore cellular homeostasis by targeting SIGMAR1 and muscarinic receptors. The ANAVEX 2-73 also exhibited anticonvulsant, anti-amnesic, neuroprotective, and anti-depressant properties in animal models, indicating its potential to treat additional CNS disorders, incl...
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Bullboard (NDAQ:AVXL)
New Post
View:
Posts & Comments
Threaded Posts
(235)
•••
coolfooldumbguy
X
Post by
coolfooldumbguy
on Nov 14, 2025 8:17am
Sell buddy sell.Wow.
Otherwise you guys out there will be losing your shorts with this stock today
(542)
•••
Galaxym31
X
Post by
Galaxym31
on Nov 13, 2025 11:51am
Who knows what we don't ?
collapse
Scaling for long-term success: A new era in gold development
posted Dec 11, 2025 9:00am by
Vista Gold Corp.
-
|
Backed by years of technical expertise and strategic discipline, Mt Todd has emerged as one of the most compelling undeveloped gold assets globally. A recently completed feasibility study signals a pivotal shift in strategy ...read more
(542)
•••
Galaxym31
X
Post by
Galaxym31
on Oct 30, 2025 12:12pm
Seems to me this drug for Alzheimer's disease should be
used to treat people worldwide ASAP. Whats the holdup ?
(542)
•••
Galaxym31
X
Post by
Galaxym31
on Oct 01, 2025 12:13pm
How can this treatment not be worth billions ?
$$$$$$
(542)
•••
Galaxym31
X
Post by
Galaxym31
on Sep 30, 2025 12:22pm
Should be much higher IMO
.
(5)
•••
hoffbag
X
Post by
hoffbag
on Nov 25, 2023 5:20pm
Not a lot of respect here….
For their data. Seems like everyone is doubting efficacy. But the approved products are NG also? Well if the pharma gods and the FDA are wrong and Anavex gets EMA approval there are
...more
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
{{previousButtonTitle}}
{{nextButtonTitle}}
A daily snapshot of everything
from market open to close.
Featured News Links
Mt Todd has emerged as one of the most compelling undeveloped gold assets globally
Lode Gold Enters into Exclusive LOI with a Mining Company to Advance Fremont Gold Project